Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products. It also provides pet nutrition products for everyday nutritional needs; a range of therapeutic products to manage disease conditions; and various products with natural ingredients. The company's principal global and regional trademarks include Colgate, Palmolive, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, elmex, Tom's of Maine, Sanex, Ajax, Axion, Fabuloso, Soupline, and Suavitel, as well as Hill's Science Diet, Hill's Prescription Diet, and Hill's Ideal Balance. It markets and sells its oral, personal and home care products to various retail and wholesale customers, and distributors; and pet nutrition products for dogs and cats through pet supply retailers and veterinarians. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Industry, Sector and Symbol
Industry Toilet preparations
Sub-IndustryHousehold Products
SectorConsumer Staples
SymbolNYSE:CL
CUSIP19416210
Phone212-310-2000
Debt
Debt-to-Equity Ratio64.85
Current Ratio1.08
Quick Ratio0.75
Price-To-Earnings
Trailing P/E Ratio22.26
Forward P/E Ratio20.35
P/E Growth2.56
Sales & Book Value
Annual Sales$15.45 billion
Price / Sales3.61
Cash Flow$3.4709 per share
Price / Cash18.41
Book Value$0.28 per share
Price / Book228.21
Profitability
EPS (Most Recent Fiscal Year)$2.87
Net Income$2.02 billion
Net Margins13.30%
Return on Equity1,486.69%
Return on Assets20.31%
Miscellaneous
Employees35,900
Outstanding Shares872,320,000
Colgate-Palmolive (NYSE:CL) Frequently Asked Questions
What is Colgate-Palmolive's stock symbol?
Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."
How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?
Colgate-Palmolive declared a quarterly dividend on Monday, June 18th. Stockholders of record on Wednesday, July 18th will be paid a dividend of $0.42 per share on Wednesday, August 15th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.63%. The ex-dividend date of this dividend is Tuesday, July 17th. View Colgate-Palmolive's Dividend History.
How were Colgate-Palmolive's earnings last quarter?
Colgate-Palmolive (NYSE:CL) announced its quarterly earnings data on Friday, April, 27th. The company reported $0.74 EPS for the quarter, beating analysts' consensus estimates of $0.73 by $0.01. The business had revenue of $4 billion for the quarter, compared to analysts' expectations of $4.01 billion. Colgate-Palmolive had a return on equity of 1,486.69% and a net margin of 13.30%. The firm's revenue was up 6.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.67 earnings per share. View Colgate-Palmolive's Earnings History.
When is Colgate-Palmolive's next earnings date?
What price target have analysts set for CL?
15 analysts have issued twelve-month price objectives for Colgate-Palmolive's shares. Their forecasts range from $66.00 to $85.00. On average, they expect Colgate-Palmolive's share price to reach $75.4545 in the next year. View Analyst Ratings for Colgate-Palmolive.
What are Wall Street analysts saying about Colgate-Palmolive stock?
Here are some recent quotes from research analysts about Colgate-Palmolive stock:
- 1. According to Zacks Investment Research, "Colgate has outperformed the industry in the last three months driven by smooth progress on its savings plan. The company is progressing well with its Global Growth and Efficiency Program along with additional savings anticipated from the recent expansion of the program. Moreover, the company has been infamous with investors for its meet or beat earnings track record. It also remains confident of the brand building and productivity maximization initiatives, which are likely to boost results. However, Colgate has been witnessing strained margins lately due to higher raw material and packaging costs, as well as advertising expenses. Though the company expects improved adjusted gross margin in 2018, it anticipates advertising costs to remain high, which should hurt operating margin. Moreover, it expects the backdrop to remain challenging in 2018. Nonetheless, estimates have been lately stable ahead of first-quarter 2018 earnings release." (4/17/2018)
- 2. Jefferies Financial Group Inc analysts commented, "CL’s 4Q print was disappointing w/org sales of +2% (vs. +3.4% Street) and GM%/OI below expectations. 4Q EPS of $0.75 was in-line with revs/GM% miss partially offset by lower SG&A and $0.02 from taxes. FY18 guide implies tepid low-to-mid single digit % underlying EPS growth (ex-Tax Act/FX benefits), which should augment HPC group GM % worries w/higher commodity costs, constrained pricing, and need for higher investment. We expect CL’s shares to trade down." (1/26/2018)
Who are some of Colgate-Palmolive's key competitors?
Some companies that are related to Colgate-Palmolive include Estee Lauder Companies (EL), Pola Orbis (PORBF), Coty (COTY), HYPERA S A/S (HYPMY), Edgewell Personal Care (EPC), Inter Parfums (IPAR), Mandom (MDOMF), Revlon (REV), e.l.f. Beauty (ELF), Avon Products (AVP), United-Guardian (UG), DS Healthcare Group (DSKX) and 2050 Motors (ETFM).
Who are Colgate-Palmolive's key executives?
Colgate-Palmolive's management team includes the folowing people:
- Mr. Ian M. Cook, Chairman, Pres & CEO (Age 65)
- Mr. Dennis J. Hickey, Vice Chairman (Age 70)
- Mr. Franck J. Moison, Vice Chairman (Age 64)
- Mr. Noel R. Wallace, Chief Operating Officer of Global Innovation & Growth and Hill's Pet Nutrition (Age 54)
- Mr. P. Justin Skala, Chief Operating Officer of North America, Europe, Africa/Eurasia and Global Sustainability (Age 58)
Has Colgate-Palmolive been receiving favorable news coverage?
News stories about CL stock have been trending somewhat positive on Wednesday, according to Accern Sentiment Analysis. The research firm identifies positive and negative press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Colgate-Palmolive earned a coverage optimism score of 0.19 on Accern's scale. They also assigned news stories about the company an impact score of 46.59 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near term.
Who are Colgate-Palmolive's major shareholders?
Colgate-Palmolive's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (6.19%), Massachusetts Financial Services Co. MA (3.34%), Northern Trust Corp (1.21%), Wells Fargo & Company MN (1.13%), First Eagle Investment Management LLC (0.90%) and OppenheimerFunds Inc. (0.73%). Company insiders that own Colgate-Palmolive stock include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Richard J Kogan, Stephen I Sadove and Victoria L Dolan. View Institutional Ownership Trends for Colgate-Palmolive.
Which institutional investors are selling Colgate-Palmolive stock?
CL stock was sold by a variety of institutional investors in the last quarter, including Alecta Pensionsforsakring Omsesidigt, Principal Financial Group Inc., Principal Financial Group Inc., Amundi Pioneer Asset Management Inc., State of New Jersey Common Pension Fund D, Swiss National Bank, Envestnet Asset Management Inc. and Lord Abbett & CO. LLC. Company insiders that have sold Colgate-Palmolive company stock in the last year include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Stephen I Sadove and Victoria L Dolan. View Insider Buying and Selling for Colgate-Palmolive.
Which institutional investors are buying Colgate-Palmolive stock?
CL stock was purchased by a variety of institutional investors in the last quarter, including Old Mutual Global Investors UK Ltd., First Eagle Investment Management LLC, BlackRock Inc., Findlay Park Partners LLP, Loomis Sayles & Co. L P, Wells Fargo & Company MN, Rockefeller Capital Management L.P. and VGI PARTNERS PTY Ltd. View Insider Buying and Selling for Colgate-Palmolive.
How do I buy shares of Colgate-Palmolive?
Shares of CL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Colgate-Palmolive's stock price today?
One share of CL stock can currently be purchased for approximately $63.90.
How big of a company is Colgate-Palmolive?
Colgate-Palmolive has a market capitalization of $55.23 billion and generates $15.45 billion in revenue each year. The company earns $2.02 billion in net income (profit) each year or $2.87 on an earnings per share basis. Colgate-Palmolive employs 35,900 workers across the globe.
How can I contact Colgate-Palmolive?
Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The company can be reached via phone at 212-310-2000 or via email at [email protected]
MarketBeat Community Rating for Colgate-Palmolive (CL)
MarketBeat's community ratings are surveys of what our community members think about Colgate-Palmolive and other stocks. Vote "Outperform" if you believe CL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CL will underperform the S&P 500 over the long term. You may vote once every thirty days.
